West Nadja sold $298K of THC

West Nadja sold 1,152 shares of TENET HEALTHCARE CORP (THC) at $258.80 ($0.30M total) on 2026-09-02.

Original reporting
SEC EDGAR · West Nadja
Published Sep 4, 2026, 12:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 12:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$THC
Neutral
medium confidence
Mentioned
$THC
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$THCNeutralLow
01

Why it matters

The transaction is a primary disclosure but modest in scale, likely causing limited price movement.

02

Market read

Insider sale provides fresh data for traders monitoring THC but is unlikely to drive major market moves.

03

What to watch

Potential upcoming corporate actions or personal tax considerations not disclosed.

Relevance 4/10Novelty 4/10Timing: filing date 2026-09-02, reported 2026-09-03

Background

Form 4 filing by a director discloses a recent open‑market sale of company stock.

Company-level read

Ticker impact

$THCNeutralMedium confidence
Context

Director West Nadja sold 1,152 shares for $298,137, reducing her stake to 23,653 shares.

Expected impact

Potential slight downward pressure on THC price in short term.

Evidence & confidence

Sale amount is under $300k and represents a small percentage of holdings; market reaction likely limited.

Market effects

Minimal impact on healthcare sector; insider sales are routine.

No significant regional effect.

Limited relevance beyond the specific stock.

Counterpoint

The sale could be unrelated to confidence and merely portfolio rebalancing.

Key entities

  • Tenet Healthcare Corp.

    US‑listed healthcare services provider (ticker THC).

  • West Nadja

    Director of Tenet Healthcare who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HCAMed

Hospital Stocks Soared as Democrats Took Congress

HCA Healthcare (HCA) rose 10.34% to $510.70 on November 4, 2026, following Democratic gains in the U.S. election. Investors anticipate potential policy changes favoring hospitals and Medicaid insurers. Universal Health Services (UHS) and Tenet Healthcare (THC) also saw significant gains. HCA's stock is now valued at $106.68 billion, but analysts warn of potential downside risks if policy changes do not materialize.

$THCHighAI 8/10

Mizuho raises Tenet Healthcare stock price target on strong results

Mizuho increased its price target for Tenet Healthcare (NYSE:THC) to $305 from $290, citing strong quarterly results and raised 2026 EBITDA estimates. The stock trades near its 52-week high after a 49% six-month surge. Tenet reported Q3 2026 EPS of $6.64, beating estimates, and raised its full-year EBITDA outlook. Guggenheim maintained a Buy rating with a slightly lowered target of $306.

$THCMed

Tenet Healthcare Q3 Earnings Call Highlights

Tenet Healthcare (THC) reported Q3 earnings, with hospital segment showing 3.2% growth in admissions and 11% adjusted EBITDA increase. Revenue per admission rose 0.2% YoY. Exchange admissions and revenues declined 18%. Conifer transition activities contributed $147M, with $450M expected in 2026. Tenet generated $1.1B in adjusted free cash flow and repurchased 970K shares.